Why is the mRNA vaccine effective against Omicron when used as a booster?
- AstraZeneca Evusheld long-acting antibody combination approved in EU for the treatment of COVID-19
- Just 2 Months of Ketogenic Diet Is Enough to Improve Brain Cognitive Function
- Do you still think Pfizer COVID-19 vaccine effective?
- How is the first batch of frozen people after 50 years?
- COVID-19 infection increases risk of a range of neurological diseases,
- Cancer patients eating ice cream can reduce this side effect of chemotherapy
Why is the mRNA vaccine effective against Omicron when used as a booster?
- New breakthrough in CAR-T cell therapy: Lupus erythematosus patients achieved treatment-free remission for up to 17 months
- Is the new COVID Omicron variant BA.4.6 more contagious?
- How long can the patient live after heart stent surgery?
- First time: Systemic multi-organ recovery after death
- Where do the bacteria in the human gut come from?
Nature: Why is the mRNA vaccine developed for the original strain effective against Omicron when used as a booster?
On April 2, 2022, researchers from The Rockefeller University in the United States published a research paper entitled: Increased Memory B Cell Potency and Breadth After a SARS-CoV-2 mRNA Boost in Nature .
The study showed that a third dose of the mRNA vaccine developed for the original new coronavirus (SARS-CoV-2) strain enhanced the immune system’s ability to produce broadly neutralizing antibodies, including the ability to produce broadly neutralizing antibodies, compared with just two doses. Antibodies that neutralize Omicron variants .
These findings help explain why mRNA vaccines based on the original 2019-nCoV strain are still effective against newly developed variants when used as boosters.
The research team analyzed blood samples from 42 people who had received three doses of the mRNA vaccine (8 with Moderna and 34 with Pfizer and BioNTech) after the first, second and third doses, respectively. collect. None of the study participants had ever been infected with the new coronavirus.
The research team observed that the blood samples after the third injection had an increased range of memory B cells compared to the blood samples after the second injection.
Memory B cells can quickly respond to the new coronavirus and produce antibodies. The antibodies produced by these cells showed better breadth and greater potency in neutralizing SARS-CoV-2 than those produced by cells after the second dose. More than 50% of these antibodies can neutralize the Omicron variant.
The research team pointed out that the increase in antibody efficacy after the third injection is because the antibodies produced by the newly emerged memory B cells can target more receptor binding domains (the receptor binding domain of the new coronavirus spike protein, which is conducive to the entry of the virus into the human body). cells) .
They added that while the third dose boosted antibody responses against multiple SARS-CoV-2 variants, it did not completely prevent breakthrough infections.
Reference:
https://www.nature.com/articles/s41586-022-04778-y
Why is the mRNA vaccine effective against Omicron when used as a booster?
(source:internet, reference only)
Disclaimer of medicaltrend.org
